Cytosorbents top shareholders

Author: flic

August undefined, 2024

WebJan 29, 2024 · A look at the shareholders of Cytosorbents Corporation ( NASDAQ:CTSO ) can tell us which group is most powerful. We can... WebOct 10, 2024 · Hedge funds don't have many shares in Cytosorbents. The company's largest shareholder is Robert Shipley, with ownership of 6.5%. With 6.1% and 4.9% of the shares outstanding respectively,...

Quite a few insiders invested in Cytosorbents Corporation

WebJun 1, 2024 · CytoSorbents Investor Relations Contact: Terri Anne Powers Vice President of Investor Relations and Corporate Communications 732-482-9984 [email protected] Public Relations Contact:... WebThe company is committed to serving the best interests of our patients and their families, our customers, our employees, and our shareholders. Are you an Investor? CytoSorb® is a unique blood purification therapy.The product is currently approved in the European Union and distributed in 58 countries around the world Are you a Healthcare Provider? diamond\u0027s bl

Amazon

WebApr 10, 2024 · Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal … WebSep 4, 2024 · Furthermore, you'd generally like to see the share price rise faster than the market. Unfortunately for shareholders, while the Cytosorbents Corporation (NASDAQ:CTSO) share price is up 80% in the ... WebApr 12, 2024 · See the latest CytoSorbents Corp stock price (NASDAQ:CTSO), related news, valuation, dividends and more to help you make your investing decisions. diamond\u0027s bk

CytoSorbents Announces Additions to its International Clinical …

CTSO - Cytosorbents Corp Shareholders - CNNMoney.com

WebJan 12, 2024 · MONMOUTH JUNCTION, N.J., Jan. 12, 2024 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO ), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology... Web23 hours ago · April 13, 2024 09:14 AM updated an hour ago. Reuters. MILAN - Stellantis shareholders on Thursday approved the compensation package for the car maker's top … cisplatin selleckchemWebApr 29, 2024 · CytoSorbents Contact: Amy Vogel Investor Relations (732) 398-5394 [email protected] Investor Relations Contact: Jeremy Feffer LifeSci Advisors (212) 915-2568 [email protected]... diamond\\u0027s birthday

"WebJun 8, 2024 · Cytosorbents is a smaller company with a market capitalization of US$112m, so it may still be flying under the radar of many institutional investors. ... A deeper look at … " - Cytosorbents top shareholders

Cytosorbents top shareholders

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims

Web1 day ago · Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 … WebOct 14, 2024 · Top Stories. Stock Market. Commodities Market. Rural News. Industries . Basic Materials. ... We regret to report that long term Cytosorbents Corporation (NASDAQ:CTSO) shareholders have had that experience, with the share price dropping 44% in three years, versus a market return of about 66%. The more recent news is of …

Did you know?

WebFeb 6, 2024 · CytoSorbents Contact: Amy Vogel Investor Relations 732-398-5394 [email protected] Investor Relations Contact: Jeremy Feffer LifeSci Advisors 917-749-1494 [email protected] Public... WebOver the past 12 years, Dr. Chan has led the company through the E.U. approval and commercialization of its flagship product, CytoSorb, as a novel blood purification therapy to treat cytokine storm and control deadly …

WebJun 2, 2024 · Terri Anne Powers Vice President, Investor Relations and Corporate Communications (732) 482-9984 [email protected] U.S. Public Relations Contact: Eric Kim Rubenstein Public Relations... WebCytoSorbents operates through its wholly-owned subsidiary, CytoSorbents Medical Inc. (fka CytoSorbents Inc.), and conducts its European business through its wholly-owned subsidiary, CytoSorbents Europe GmbH, with daughter subsidiaries in the United Kingdom, Switzerland, and Poland.

WebNov 4, 2024 · CytoSorbents is conducting its pivotal REFRESH 2-AKI trial – a multi-center, randomized controlled, clinical trial intended to support U.S. regulatory approval of CytoSorb for use in a heart ... WebCytoSorbents is covered by 7 analysts from Cowen & Co., SVB Leerink, Jefferies, H.C. Wainwright, B. Riley, Dawson James, and Maxim, and is part of the Russell 2000 and …

WebFeb 24, 2024 · Feb. 24, 2024, 07:00 AM. MONMOUTH JUNCTION, N.J., Feb. 24, 2024 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive ...

Web1 day ago · Top global miner BHP Group is expected to secure the backing of Oz Minerals shareholders for its A$9.6 billion ($6.4 billion) buyout at a vote on Thursday, reflecting … cisplatin researchWebApr 4, 2024 · Of the 39 institutional investors that sold Cytosorbents stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: … diamond\\u0027s birthday buffetWebApr 8, 2024 · Last modified on Sat 8 Apr 2024 02.34 EDT. Metro Bank is at risk of a shareholder rebellion over executive pay, after an influential investor advisory firm said … diamond\u0027s birthday buffetWebCytoSorbents is covered by 7 analysts from Cowen & Co., SVB Leerink, Jefferies, H.C. Wainwright, B. Riley, Dawson James, and Maxim, and is part of the Russell 2000 and … cisplatin salt wastingWebMar 10, 2024 · On Friday 03/10/2024 the closing price of the Cytosorbents Corp share was $3.58 on NAS. Compared to the opening price on Friday 03/10/2024 on NAS of $3.66, this is a drop of 2.23%. diamond\u0027s bmWebApr 24, 2015 · /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: ... CytoSorbents Issues Letter to Shareholders News provided by. CytoSorbents Corporation Apr 24, 2015, 08:00 ET. Share this article. diamond\\u0027s boWeb2 days ago · The company plans to target $115 billion of free cash flow available for shareholder distributions by 2033. ConocoPhillips said it expects to generate a 6% … diamond\\u0027s bl